Search

IBI-Ag

Pioneering Next-Generation Crop Protection

IBI-Ag's pest control solutions are not only highly effective but also safe, sustainable and commercially viable at scale. The company's innovative use of AI de-novo approach to design biological insecticides is poised to revolutionize the crop protection industry

Share to Facebook
Share to X

Article printing is available to subscribers only

Print in a simple, ad-free format

Subscribe
IBI-Ag 1
IBI-Ag 1
IBI-Ag's next-gerneration biological insecticide being applied to field crops Credit: IBI-Ag
IBI-Ag's next-gerneration biological insecticide being applied to field crops Credit: IBI-Ag
Rebecca Kopans, partnered with IBI-Ag
Promoted Content

One of the greatest challenges facing the agricultural sector is how to cope with pests that destroy crops. Indeed, up to 30% of agricultural produce is routinely lost due to pest damage. Traditional chemical insecticides suffer from many drawbacks, including the rapid development of pest resistance. Moreover, chemical insecticides are neither sustainable nor environmentally friendly, and global markets, driven by regulation as well as consumer concerns, are increasingly rejecting the use of chemicals on food products.

Scientists around the world are therefore racing to develop more effective and sustainable crop protection solutions to ensure that the global food supply can continue feeding a rapidly growing population.

Precision bioinsecticides

The Israeli AgTech company IBI-Ag is a pioneer in the field of next-generation insecticides that are biological rather than chemical—and therefore safer, sustainable and more efficient than existing alternatives. Founded in 2017, the company has developed a new class of biological insecticides with a fundamentally different mode of action. IBI-Ag's first generation of innovative biological insecticides, currently in advanced field trials in the United States and Israel, consist of single domain antibodies that are effective against key insect pest species.

"Our disruptive IP is based on insect targets validated in vivo with an extensive library of single domain antibodies," affirms IBI-Ag CEO Dr. Arnon Heyman, adding that, "our bioinsecticides are built on protein-based active ingredients, engineered to bind with precision to specific target proteins within the insect's digestive system, disrupting essential biological functions with minimal off-target effects."

Heyman is proud that his company is successfully advancing the registration of its first product, and that IBI-Ag's bioinsecticides are demonstrating good efficacy in the field.

Groundbreaking use of AI

This year, IBI-Ag reached a milestone with the development of the world's first proof-of-concept for an AI-driven bioinsecticide protein design platform. "We are probably the first bioinsecticide company in the world to successfully design insecticidal mini-proteins using AI," says Dr. Heyman. "Rather than developing proteins in a lab, which takes a long time, we are leveraging our IP and now using artificial intelligence to design insecticidal proteins de novo. we then test and validate these candidates in the lab. By using an AI-assisted de novo approach, the development process now only takes as little as a few months from in silico (on the computer) to in vivo (in a living organism) testing," he explains.

This innovative methodology is a true paradigm shift for the bioinsecticide industry, since it is so much faster and more efficient, as well as sustainable. By leveraging IBI-Ag's proprietary IP, new proteins are rapidly discovered and validated based on vast amounts of data, thereby opening up many new markets by targeting insect challenges that were previously unattainable with naturally occurring proteins. The new methodology may also lower production costs and increase product stability and resiliency.

For more information, visit www.ibi-ag.com

Partnered with IBI-Ag

Back to article

Labels

Promoted Content

    ICYMI

    Judge Yuji Iwasawa, president of the International Court of Justice, presides over the court on the day it delivered its judgment in the case brought by Gambia accusing Myanmar of genocide against the Rohingya Muslim minority, in The Hague, Netherlands, Thursday.

    Myanmar's Genocide Conviction Should Terrify Israel

    Nir Hasson
    Caretaker Prime Minister Benjamin Netanyahu looks on during a speech at the Knesset on the opening day of the new parliament in Jerusalem on November 10, 2026.

    Netanyahu's 10-Point 'Unity' Offer to Eisenkot: He Stays PM, No Oct. 7 Inquiry

    Michael Hauser Tov
    כנס אוונגליסטים בבנייני האומה

    Faith in Jesus, Jewish Traditions: Inside Israel's Growing Messianic Movement

    Noa Limone
    Gadi Eisenkot and Naftali Bennett shaking hands as they celebrate the election of Matan Kahana, left, as Knesset speaker this week.

    Netanyahu Lost. So Why Are His Rivals Fumbling?

    Yossi Verter
    Hannah Lillith Assadi, winner of the 2026 National Book Award for Fiction, arrives at the 77th National Book Awards on Wednesday, Nov. 18, 2026, at Cipriani Wall Street in New York.

    A Palestinian Story of Exile Takes One of America's Top Literary Prizes

    Etan Nechin
    Ohana. "Supporters of fascism follow the heart; they follow a feeling, an emotion. It's a collective emotion, brimming with adrenaline. It's fun to be a fascist."

    An Israeli Historian's Unsettling Explanation for the Rise of Fascism: It's Fun!